The use of an enzyme-membrane-reactor in the enzymatic production of L-DOPA (which is commonly employed as a drug used for treatment of Parkinson's disease 161 ) from tyrosine offers numerous advantages. By continuously supplying L-tyrosine to the biocatalytic system at a controlled rate, the EMR helps preventing enzyme inhibition and maintaining a constant substrate concentration.